Impact of COVID-19 delays on skin cancer worry and Mohs micrographic surgery for keratinocytic carcinoma - 16/09/22
, Inge J. Veldhuizen, MD b, Aleisa Abdullah, MD b, Anthony Rossi, MD b, Kishwer S. Nehal, MD b, Chrysalyne Schmults, MD, MSCE a, Abigail Waldman, MD a, Erica H. Lee, MD bKey words : basal cell carcinoma, COVID-19, cutaneous squamous cell carcinoma, Mohs micrographic surgery
| Funding sources: This research was funded, in part, by the National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748. The funder had no role in the design and conduct of the study: collection, management, analysis, and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication. |
|
| IRB approval status: Reviewed and approved by the Partners (2020P001143) and Memorial Sloan Kettering (18-168) Cancer Center Human Research Office. |
Vol 87 - N° 4
P. 878-880 - octobre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
